Health Mar 16, 2025

Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?

MedPage Today) -- A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously untreated, high-risk locally advanced cervical cancer, according to results from the KEYNOTE-A18 trial...

Related News

View All

Health Aug 18, 2025

A stroke stole her abilit...

Health Aug 18, 2025

COVID infection ages bloo...

Health Aug 18, 2025

Ketamine use in chronic p...

Health Aug 18, 2025

Can You Actually Turn Bac...

Health Aug 18, 2025

Kid Cudi’s Music Is a L...

Health Aug 18, 2025

9 Men Share How Getting P...

Health Aug 18, 2025

There’s 1 Big Reason Ev...

Health Aug 18, 2025

Amazon Home Gym Equipment...

Trending News

Health May 18, 2025

Glial cells may play key ...

Health May 18, 2025

So your primary school ch...

Health May 18, 2025

On the sidelines no more:...

Health May 18, 2025

You Need More Than 8-Minu...

Health May 18, 2025

Mission: Impossible Is Al...

Health May 18, 2025

Andor Season 2 Uses an Of...

Health May 18, 2025

The 9 Best SPF Moisturize...

Trending

Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?

Related News

Trending News

Tags

Get In Touch

Follow Us

Popular News

Categories

Flickr Photos